The Bone Cancer Research Trust is committed to funding fund high impact, innovative and collaborative research with the aim of improving outcomes for patients.
Funding of up to £35,000 is available to support pilot projects focused on osteosarcoma and / or Ewing sarcoma that demonstrate a line of sight to patient benefit.
Funding is available to researchers and / or clinicians working in an academic or clinical institution in the UK or internationally. Applications from earlier career academics, who do not have a tenured position are encouraged.
Applications should be both hypotheses driven and generating. They should clearly describe background evidence (including figures) that have been used to support the submitted project and should describe how the experimental design will answer the questions posed in the project.
Projects may be discovery focused, where novel research ideas are tested, or proof of concept studies aiming to generate preliminary data for subsequent applications. This funding call can also provide funds for small translational projects that show potential and may pave the way for future major research. Regardless of this focus, applicants must demonstrate that they have considered how the project may result in patient benefit or clinical application, irrespectively of timescales.
Patient involvement in the development of applications will be expected. The Bone Cancer Research Trust has a Patient and Public Involvement Panel, who may be contacted to support your application. Please email us at research@bcrt.org.uk.
Key dates
Call opens 24th March 2025
Closing date for applications: 23rd June 2025
Outcomes will be announced by September 2025
International applicants are eligible to serve as principal investigators but must ensure the inclusion of a co-applicant or collaborator based at a UK institution in their application
Sponsor Institute/Organizations: Bone Cancer research Trust
Sponsor Type: Corporate/Non-Profit
Address: 10 Feast Field Horsforth Leeds LS18 4TJ 0113 258 5934
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jun 23, 2025
Jun 23, 2025
$46,429
Affiliation: Bone Cancer research Trust
Address: 10 Feast Field Horsforth Leeds LS18 4TJ 0113 258 5934
Website URL: https://www.bcrt.org.uk/research/for-researchers/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.